– September 1, 2003
September 1, 2003
View Issues
-
Changes Due to Radiation Fibrosis Can Be Reversible with a Simple Oral Regimen
Investigators in Paris performed a follow-up phase III randomized trial to confirm the efficacy and synergism of pentoxifylline and alpha-tocopherol as an antifibrotic treatment in women who had received previous breast radiotherapy. -
Choosing the Right Chemotherapy for Elderly NSCL Cancer Patients
The current report examines the importance of patient age with regard to toxicity and response rates when treated with carboplatin and paclitaxel for advanced lung cancer. Similar toxicity profiles were observed in those younger or older than 70 years of age, and response rates were also similar. -
Breast Cancer and HRT: The Million Woman Study
The Million Women Study, a cohort study of a quarter of all British women aged 50-64, was undertaken to investigate the relationship between the various patterns of HRT use and breast cancer incidence and mortality. -
Weekly Cisplatin and Gemcitabine with Concurrent Radiotherapy in Locally Advanced Cervical Carcinoma
Cervical cancer is the most frequent gynecologic cancer in the world and the most frequent cancer in women in many underdeveloped and developing countries, where almost half of the patients are diagnosed with locally advanced disease. -
Hepatitis C and Non-Hodgkin’s Lymphoma: An Association Clarified
In this multicenter Italian study the prevalence of hepatitis C infection (HCV) was 17.5% among 400 newly diagnosed non-Hodgkins lymphoma patients compared to 5.6% among controls, confirming an association between these 2 disorders. -
Pharmacology Watch: Study Shows Oral IIb/IIIa Receptors Increase Mortality
Another study has shown an increase in mortality associated with the use of an oral IIb/IIIa receptor antagonist.